RxDoctor Payments DataLook up a doctor →

Riquel Gonzalez, DPM

Foot & Ankle Surgery · Hialeah, FLNPI 1457693566

Payments from drug & device makers

$612,365in general payments, 2019–2025

Across 217 payments — averaging $2821.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cleerly, Inc.$452K
  • Sun Pharmaceutical Industries Inc.$81K
  • Vilex LLC$40K
  • Royal Biologics, Inc.$27K
  • Musculoskeletal Transplant Foundation Inc.$3K
  • Arthrex$2K
  • plus $8K from 31 others

What the payments were for

  • Consulting fees$26,78651%
  • Travel & lodging$13,52026%
  • Food & beverage$10,31420%
  • Education$1,8374%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$612,365 in reported general payments places this provider in the 95th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$80,198
Medicare patients
165
Services billed
700

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine1,310$28,910
Ammonium Lactate1,085$22,285
JubliaEfinaconazole14$13,113
XareltoRivaroxaban11$5,896
SantylCollagenase Clostridium Hist.17$5,714
Linezolid15$4,355
Gentamicin Sulfate72$4,203
Ciclopirox78$3,308
Ketoconazole184$3,047
Diclofenac Sodium145$2,406
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip121$2,280
Gabapentin234$2,167
Mupirocin184$1,828
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen136$1,230
Oxycodone Hcl31$1,100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$432$5,71417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 850 foot & ankle surgery providers in Florida.

Other foot & ankle surgery in Hialeah

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →